Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Methylphenidate may help relieve fatigue caused by cancer. It is not yet known
whether methylphenidate is more effective than a placebo in relieving fatigue and improving
quality of life in patients with cancer.
PURPOSE: This randomized phase III trial is studying methylphenidate to see how well it works
in treating patients with fatigue caused by cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborators:
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. National Cancer Institute (NCI)